Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer

Lingling Hu, LAN-XIANG CONG|Oncology Reports|2015

Cited by 31